CMG Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
CMG Pharmaceutical has a total shareholder equity of ₩196.0B and total debt of ₩76.1B, which brings its debt-to-equity ratio to 38.8%. Its total assets and total liabilities are ₩304.7B and ₩108.7B respectively.
Key information
38.8%
Debt to equity ratio
₩76.12b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩82.84b |
| Equity | ₩196.03b |
| Total liabilities | ₩108.69b |
| Total assets | ₩304.72b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A058820's short term assets (₩133.2B) exceed its short term liabilities (₩83.3B).
Long Term Liabilities: A058820's short term assets (₩133.2B) exceed its long term liabilities (₩25.4B).
Debt to Equity History and Analysis
Debt Level: A058820 has more cash than its total debt.
Reducing Debt: A058820's debt to equity ratio has increased from 0% to 38.8% over the past 5 years.
Debt Coverage: A058820's debt is not well covered by operating cash flow (10.3%).
Interest Coverage: Insufficient data to determine if A058820's interest payments on its debt are well covered by EBIT.